$BIIB

BULLISH2022-11-30

By horizon✗ miss-5.6%

✗ -2.7%

✗ -0.7%

21d

✗ -5.6%

Original post

Andy Biotech · 2022-11-30

$BIIB My thought on lecanemab "clinical meaningfulness" debate: 18-mo rx slowed disease progression by 6~8mo. Is it not meaningful to pts and families to have 6~8 more months of your memory and freedom? An oncology drug w/ 6~8mo of PFS benefit would be heralded as breakthrough! https://t.co/9FNFbSSKrP

View on X ↗